SCHEMBL7422882

SCHEMBL7422882

N#CCC1(NC(=O)C(CC2CCCCC2)Nc2nsc3ccccc23)CCNCC1

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CTSS P25774 12/20 0.38
CTSL P07711 10/20 0.38
CTSB P07858 3/20 0.37
CTSK P43235 1/20 0.37
CTSC P53634 1/20 0.30
JAK2 O60674 1/20 0.30
JAK1 P23458 1/20 0.30
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417521 0.84 CTSS (0.38) CTSSCTSLCTSBCTSK
SCHEMBL5357493 0.79 CTSS (0.53) CTSSCTSLCTSBCTSK
SCHEMBL5363187 0.78 CTSS (0.39) CTSSCTSLCTSBCTSK
SCHEMBL7012870 0.75 CTSS (0.41) CTSSCTSLCTSBCTSKJAK2
SCHEMBL7008282 0.73 CTSL (0.40) CTSSCTSLCTSBCTSK
SCHEMBL7004000 0.73 CTSS (0.50) CTSSCTSLCTSBCTSK
SCHEMBL7007715 0.71 CTSS (0.39) CTSSCTSLCTSBCTSKCTSC
SCHEMBL7010006 0.70 CTSS (0.49) CTSSCTSLCTSBCTSK
SCHEMBL7415395 0.70 CTSS (0.38) CTSSCTSLCTSBCTSK
SCHEMBL7418241 0.70 CTSL (0.34) CTSSCTSLCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed